Sen. Menendez Leads Colleagues Call to Big Pharma to Prioritize Diversity in COVID-19 Clinical Trials
April 22, 2020
April 22, 2020
NEWARK, New Jersey, April 22 -- Sen. Robert Menendez, D-New Jersey, issued the following news release:
U.S. Senator Bob Menendez (D-N.J.), a senior member of the Senate Finance Committee that sets national health policy, led a group of colleagues in urging 15 pharmaceutical companies engaged in COVID-19 related work and their trade organization to prioritize diversity in any coronavirus vaccine or trial. Given the disproportionate impact of the outbreak on communities of color and o . . .
U.S. Senator Bob Menendez (D-N.J.), a senior member of the Senate Finance Committee that sets national health policy, led a group of colleagues in urging 15 pharmaceutical companies engaged in COVID-19 related work and their trade organization to prioritize diversity in any coronavirus vaccine or trial. Given the disproportionate impact of the outbreak on communities of color and o . . .